Long intergenic non-protein coding RNA 2915 (LINC02915)

Long intergenic non-protein coding RNA 2915 (LINC02915) is a member of the long intergenic non-coding RNA (lincRNA) family, transcribed from a region on chromosome 15q14. Like other lincRNAs, LINC02915 does not encode a protein and is instead believed to regulate gene expression at the transcriptional and post-transcriptional level[1][6][7]. In published functional genomics data, LINC02915 has been identified as part of regulatory networks where it may function as a competing endogenous RNA (ceRNA), sponging specific microRNAs to modulate downstream mRNA targets[2]. Its expression has been found in the cytoplasm, consistent with this regulatory role[2]. While lincRNAs in general are implicated in fundamental processes such as epigenetic modulation, chromatin remodeling, and cellular differentiation[3][5], there is currently no evidence that LINC02915 uniquely acts as a conventional receptor, enzyme, or other "druggable" therapeutic target, nor are there known drug interactions or biomarker uses specific to this lincRNA[2][6][7]. Its biological relevance and disease roles are still emerging, with some evidence suggesting possible involvement in disease-related regulatory networks, such as in acute respiratory distress syndrome (ARDS)[2]. Overall, LINC02915 represents a non-coding RNA gene with potential regulatory function but is not regarded as a direct therapeutic target.

Other names

LINC02915C15orf54FLJ39531Putative uncharacterized protein encoded by LINC02915

Acts as a ceRNA (competing endogenous RNA) to sponge microRNAs and regulate mRNA expression